| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,590 |
32,898 |
$2.42M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,190 |
29,764 |
$1.81M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,782 |
7,466 |
$333K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,733 |
3,429 |
$318K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,007 |
2,881 |
$264K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,318 |
2,192 |
$195K |
| 99215 |
Prolong outpt/office vis |
1,697 |
1,495 |
$170K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,658 |
1,581 |
$153K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,072 |
1,008 |
$137K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,032 |
1,011 |
$90K |
| 90837 |
Psychotherapy, 53 minutes with patient |
906 |
587 |
$77K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
772 |
745 |
$76K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
520 |
491 |
$72K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
2,580 |
2,392 |
$71K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,581 |
1,056 |
$70K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,205 |
835 |
$69K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,075 |
1,026 |
$64K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,827 |
1,621 |
$61K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,121 |
2,972 |
$51K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,944 |
2,741 |
$50K |
| 96127 |
|
4,645 |
3,685 |
$47K |
| 90791 |
Psychiatric diagnostic evaluation |
528 |
489 |
$42K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
399 |
375 |
$37K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,419 |
1,017 |
$29K |
| 90688 |
|
2,789 |
2,682 |
$17K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,549 |
1,426 |
$15K |
| 99201 |
|
488 |
415 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,043 |
965 |
$14K |
| 99381 |
|
123 |
120 |
$12K |
| D0145 |
Oral evaluation for a patient under three years of age |
390 |
372 |
$11K |
| 93000 |
|
664 |
610 |
$11K |
| D1206 |
Topical application of fluoride varnish |
680 |
649 |
$10K |
| 90670 |
|
2,506 |
2,420 |
$9K |
| 0002A |
|
225 |
213 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
181 |
153 |
$7K |
| 99383 |
|
64 |
57 |
$6K |
| 0001A |
|
187 |
170 |
$6K |
| 90715 |
|
147 |
141 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
52 |
52 |
$5K |
| 90686 |
|
619 |
588 |
$3K |
| 81002 |
|
873 |
747 |
$2K |
| 90723 |
|
1,556 |
1,510 |
$2K |
| 99205 |
Prolong outpt/office vis |
21 |
13 |
$2K |
| 0012A |
|
57 |
56 |
$2K |
| 99000 |
|
888 |
787 |
$2K |
| 87634 |
|
28 |
28 |
$2K |
| 90680 |
|
1,149 |
1,110 |
$2K |
| 0011A |
|
85 |
85 |
$2K |
| 90651 |
|
48 |
47 |
$2K |
| 17110 |
|
73 |
71 |
$2K |
| 90734 |
|
97 |
91 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15 |
14 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
115 |
93 |
$1K |
| 87807 |
|
125 |
113 |
$1K |
| 99382 |
|
12 |
12 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
86 |
75 |
$1K |
| 99072 |
|
173 |
162 |
$1K |
| 85018 |
|
389 |
365 |
$959.14 |
| 90647 |
|
1,540 |
1,498 |
$941.14 |
| 90633 |
|
764 |
723 |
$916.23 |
| 80305 |
|
75 |
75 |
$869.83 |
| 90785 |
|
253 |
126 |
$854.99 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
16 |
16 |
$583.50 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15 |
15 |
$520.03 |
| D0190 |
|
64 |
60 |
$518.99 |
| 0053A |
|
12 |
12 |
$494.16 |
| 90461 |
|
1,301 |
1,280 |
$487.50 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
56 |
43 |
$471.44 |
| 0003A |
|
14 |
14 |
$452.98 |
| 99406 |
|
36 |
31 |
$412.66 |
| 36416 |
|
124 |
95 |
$305.85 |
| 81025 |
|
42 |
37 |
$295.48 |
| 11721 |
|
39 |
38 |
$252.24 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16 |
13 |
$218.40 |
| 11900 |
|
15 |
12 |
$193.05 |
| 80061 |
Lipid panel |
35 |
29 |
$192.03 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
61 |
57 |
$169.32 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$166.53 |
| 11056 |
|
41 |
37 |
$157.31 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
1,716 |
1,560 |
$136.63 |
| 90685 |
|
464 |
416 |
$117.06 |
| 36415 |
Collection of venous blood by venipuncture |
41 |
35 |
$96.22 |
| 96160 |
|
302 |
284 |
$10.56 |
| 91300 |
|
451 |
381 |
$0.15 |
| 1125F |
|
830 |
713 |
$0.00 |
| 3008F |
|
207 |
156 |
$0.00 |
| 3074F |
|
61 |
43 |
$0.00 |
| 3352F |
|
123 |
102 |
$0.00 |
| 91301 |
|
145 |
141 |
$0.00 |
| 91305 |
|
16 |
16 |
$0.00 |
| 80050 |
General health panel |
18 |
12 |
$0.00 |
| 90696 |
|
13 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |
| 90716 |
|
26 |
26 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
84 |
73 |
$0.00 |
| 90700 |
|
78 |
77 |
$0.00 |
| 1159F |
|
263 |
199 |
$0.00 |
| 1160F |
|
263 |
199 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
28 |
25 |
$0.00 |
| 3078F |
|
17 |
12 |
$0.00 |
| G8511 |
Screening for depression documented as positive, follow-up plan not documented, reason not given |
80 |
80 |
$0.00 |
| S9449 |
Weight management classes, non-physician provider, per session |
208 |
166 |
$0.00 |
| 90710 |
|
27 |
25 |
$0.00 |
| 90707 |
|
42 |
40 |
$0.00 |